CHI3L1 promotes macrophage pyroptosis in ulcerative colitis via the BCAT1/NF-κB axis
Life Sciences · 2026-01 · 384 · 124108
DOI: 10.1016/j.lfs.2025.124108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026-01. Verfasst von Jie Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, China; Jiangsu Institute of Clinical Immunology, The Fir…. Hauptthemen laut MEDLINE: Pyroptosis, Colitis, Ulcerative, NF-kappa B, Chitinase-3-Like Protein 1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory bowel disease marked by intestinal epithelial damage. Although pyroptosis is implicated in the pathogenesis of UC, the key regulators of this process remain unclear. Chitinase-3-like protein 1 (CHI3L1) is upregulated in multiple inflammatory conditions and has been proposed as a fecal biomarker for endoscopic activity in inflammatory bowel disease (IBD). This study investigates the role of CHI3L1 in regulating macrophage pyroptosis in UC. METHODS: We analyzed CHI3L1 expression in UC patient colon tissues using GEO datasets and immunohistochemistry. Functional effects of CHI3L1 were examined through genetic silencing and pharmacological inhibition in THP-1 macrophages and a dextran sulfate sodium (DSS)-induced murine colitis model. RNA sequencing was performed to identify downstream factors. Mechanisms were further validated via NF-κB pathway activation assays. RESULTS: CHI3L1 was significantly upregulated in UC patients and strongly correlated with NLR Family Pyrin Domain Containing 3 (NLRP3) inflammasome expression. Both CHI3L1 knockdown and inhibitor treatment attenuated pyroptosis in vitro and ameliorated colitis in mice. RNA-seq revealed branched-chain amino acid transaminase 1 (BCAT1) as a key downstream target of the pathway. CHI3L1 promoted pyroptosis via BCAT1-mediated activation of NF-κB signaling, and exogenous NF-κB activation reversed the protective effects of CHI3L1 inhibition. CONCLUSION: This study demonstrates that CHI3L1 promotes macrophage pyroptosis in UC via the BCAT1/NF-κB axis, highlighting its potential as a therapeutic target for ulcerative colitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, China; Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, China; Jiangsu K…
- Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, China. Electronic address: xqhxqhxqh@126.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Feng, J., Zhang, H., Zhu, M., Zhang, Q., Rong, H., Shi, T., & Xi, Q. (2026). CHI3L1 promotes macrophage pyroptosis in ulcerative colitis via the BCAT1/NF-κB axis. Life Sciences, 384, 124108. https://doi.org/10.1016/j.lfs.2025.124108
Vancouver
Feng J, Zhang H, Zhu M, Zhang Q, Rong H, Shi T, et al. CHI3L1 promotes macrophage pyroptosis in ulcerative colitis via the BCAT1/NF-κB axis. Life Sciences. 2026;384:124108. doi:10.1016/j.lfs.2025.124108
BibTeX
@article{Feng2026,
author = {Feng, Jie and Zhang, Huan and Zhu, Mengxin and Zhang, Qinpei and Rong, Haokun and Shi, Tongguo and Xi, Qinhua},
title = {CHI3L1 promotes macrophage pyroptosis in ulcerative colitis via the BCAT1/NF-κB axis},
journal = {Life Sciences},
year = {2026},
volume = {384},
pages = {124108},
doi = {10.1016/j.lfs.2025.124108}
}
EUVIMED